ALX Oncology Holdings Inc
NASDAQ:ALXO

Watchlist Manager
ALX Oncology Holdings Inc Logo
ALX Oncology Holdings Inc
NASDAQ:ALXO
Watchlist
Price: 0.5735 USD -1.12%
Market Cap: 30.6m USD

Net Margin
ALX Oncology Holdings Inc

0%
Current
0%
Average
-6.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-130m
/
Revenue
0

Net Margin Across Competitors

ALX Oncology Holdings Inc
Glance View

Market Cap
30.4m USD
Industry
Biotechnology

ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. The company is headquartered in South San Francisco, California and currently employs 43 full-time employees. The company went IPO on 2020-07-17. The firm is focused on helping patients fight cancer by developing a pipeline of product candidates based on protein engineering and oncology led by the cluster of differentiation 47 (CD47) blocker. The company is developing a checkpoint inhibitor designed to have an affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches. Its lead product candidate, evorpacept, is a CD47 blocking biologic in development as a combination therapy with other anti-cancer agents for treatment of various oncology indications, including myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), head and neck squamous cell carcinomas (HNSCC), gastric and breast cancer. Its preclinical program is focused on developing ALTA-002, which combines its signal regulatory protein alpha (SIRPa) and toll-like receptor 9 agonist antibody conjugate (TRAAC).

ALXO Intrinsic Value
Not Available
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-130m
/
Revenue
0
What is the Net Margin of ALX Oncology Holdings Inc?

Based on ALX Oncology Holdings Inc's most recent financial statements, the company has Net Margin of 0%.

Back to Top